Sanvita Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
- Paid Up Capital ₹ 6.52 Cr
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 142.19 Cr
- Satisfied Charges ₹ 45.00 Cr
- Revenue Growth 30.29%
- Profit Growth -759.49%
- Ebitda -225.95%
- Net Worth -27.73%
- Total Assets 1.51%
About Sanvita Biotechnologies
Sanvita Biotechnologies Private Limited (SBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 May 2010 and has a history of 14 years and nine months. Its registered office is in Medak, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 6.52 Cr.
The company currently has active open charges totaling ₹142.19 Cr. The company has closed loans amounting to ₹45.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanvita Biotechnologies Private Limited India are Hindustan Azad as CEO and Bhavaraju Rao as Company Secretary. Amith Pinipe, Krishna Pinipe, Krishnama Sribhashyam, and Five other members serve as directors at the Company.
Company Details
-
Location
Medak, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TG2010PTC068348
-
Company No.
068348
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 May 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sanvita Biotechnologies?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Pinipe
|
Managing Director | 12-Feb-2020 | Current |
| Hindustan Azad | CEO | 26-Apr-2023 | Current |
|
Bhavaraju Rao
|
Company Secretary | 12-Apr-2021 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srikanth Pinipe
|
Director | 31-Jul-2018 | Current |
|
Amith Pinipe
|
Whole-Time Director | 12-Feb-2020 | Current |
|
Krishnama Sribhashyam
|
Whole-Time Director | 02-Apr-2015 | Current |
|
Pinipe Baby
|
Director | 12-Apr-2021 | Current |
|
Katterapalli Reddy
|
Whole-Time Director | 26-Mar-2022 | Current |
|
Modem Hemanth
|
Whole-Time Director | 11-May-2021 | Current |
Financial Performance of Sanvita Biotechnologies.
Sanvita Biotechnologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.29% increase. The company also saw a substantial fall in profitability, with a 759.49% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanvita Biotechnologies?
In 2023, Sanvita Biotechnologies had a promoter holding of 55.95% and a public holding of 44.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rep Electronic Payment Services Private LimitedModem Hemanth is a mutual person
-
Vacphar Life Sciences Private LimitedAmith Pinipe is a mutual person
-
Pinipe Projects Private Limited
Amith Pinipe, Krishna Pinipe and 2 more are mutual person
-
Saaphalya Beverages And Distillers Private Limited
Katterapalli Reddy is a mutual person
-
Vsk Services Private Limited
Katterapalli Reddy is a mutual person
-
Rep Beverages Private Limited
Modem Hemanth is a mutual person
Charges (Loans)
₹142.19 Cr
₹45.00 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 63.89 Cr
- Syndicate Bank : 48.18 Cr
- Others : 30.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2021 | Canara Bank | ₹63.89 Cr | Open |
| 09 Dec 2016 | Others | ₹15.12 Cr | Open |
| 19 Dec 2015 | Others | ₹15.00 Cr | Open |
| 08 Sep 2014 | Syndicate Bank | ₹48.18 Cr | Open |
| 08 Jul 2013 | State Bank Of India | ₹45.00 Cr | Satisfied |
How Many Employees Work at Sanvita Biotechnologies?
Sanvita Biotechnologies has a workforce of 101 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanvita Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanvita Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
